INNOVENT AND UNION THERAPEUTICS ENTER INTO STRATEGIC COLLABORATION AND LICENSE AGREEMENT FOR ORISMILAST, A NEXT-GENERATION PDE4 INHIBITOR FOR INFLAMMATORY
This document is hosted externally.
Unless the owner has removed it from the web, you can access the full document via its original URL:
http://iis.aastocks.com/20210928/9950520-0.PDFUnless the owner has removed it from the web, you can access the full document via its original URL:
See similar contracts (1)
Alternatively, you can try searching for similar contracts:
